(ACN) Accenture - Ratings and Ratios

Exchange: NYSE • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00B4BNMY34

ACN: Strategy, Consulting, Technology, Services, Automation, Robotics

Accenture plc (NYSE:ACN) stands as a global powerhouse in professional services, delivering a comprehensive suite of offerings including strategy, consulting, digital transformation, and operations. With a robust presence across North America, Europe, the Middle East, Africa, and other international markets, Accenture is a key player in driving business modernization and digital innovation.

The companys service portfolio is extensive, encompassing systems integration, application management, cybersecurity, cloud computing, and AI-driven solutions. Their expertise in software engineering and automation is particularly notable, aiding businesses in enhancing operational efficiency and technological adaptability. Additionally, Accenture ventures into designing and manufacturing automation equipment and robotics, showcasing their commitment to end-to-end innovation.

Accenture serves a diverse array of industries, including communications, media, technology, banking, insurance, healthcare, consumer goods, and industrial sectors. This broad reach underscores their ability to cater to varied business needs, making them a versatile partner for organizations across different markets.

In the realm of innovation, Accenture collaborates with esteemed institutions like Kyoto University to advance human-centered AI. This partnership highlights their dedication to ethical and impactful technological advancements, aligning with forward-thinking investor interests.

From a financial standpoint, Accenture boasts an impressive market capitalization exceeding $242 billion, reflecting its market leadership. The P/E ratio of 32.46 and forward P/E of 30.49 suggest sustained growth expectations. The price-to-sales ratio of 3.73 underscores the companys revenue generation efficiency, making it an attractive consideration for investors seeking scalable growth in the IT services sector.

Additional Sources for ACN Stock

ACN Stock Overview

Market Cap in USD 242,686m
Sector Technology
Industry Information Technology Services
GiC Sub-Industry IT Consulting & Other Services
IPO / Inception 2001-07-19

ACN Stock Ratings

Growth 5y 59.2%
Fundamental 69.0%
Dividend 66.0%
Rel. Strength Industry -13.5
Analysts 4.15/5
Fair Price Momentum 356.40 USD
Fair Price DCF 270.48 USD

ACN Dividends

Dividend Yield 12m 1.58%
Yield on Cost 5y 2.92%
Annual Growth 5y 10.28%
Payout Consistency 98.9%

ACN Growth Ratios

Growth Correlation 3m 53.1%
Growth Correlation 12m 50.3%
Growth Correlation 5y 72.6%
CAGR 5y 13.90%
CAGR/Max DD 5y 0.35
Sharpe Ratio 12m -0.05
Alpha -9.53
Beta 0.32
Volatility 20.48%
Current Volume 3751.7k
Average Volume 20d 2739.8k
What is the price of ACN stocks?
As of February 22, 2025, the stock is trading at USD 364.26 with a total of 3,751,659 shares traded.
Over the past week, the price has changed by -6.12%, over one month by +2.20%, over three months by +1.32% and over the past year by +2.61%.
Is Accenture a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Accenture (NYSE:ACN) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 68.97 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACN as of February 2025 is 356.40. This means that ACN is currently overvalued and has a potential downside of -2.16%.
Is ACN a buy, sell or hold?
Accenture has received a consensus analysts rating of 4.15. Therefor, it is recommend to buy ACN.
  • Strong Buy: 13
  • Buy: 5
  • Hold: 7
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ACN stock price target?
According to ValueRays Forecast Model, ACN Accenture will be worth about 400.1 in February 2026. The stock is currently trading at 364.26. This means that the stock has a potential upside of +9.84%.
Issuer Forecast Upside
Wallstreet Target Price 400.3 9.9%
Analysts Target Price 395 8.4%
ValueRay Target Price 400.1 9.8%